A 2019 policy resolution that calls for the AAFP to support the safety and efficacy of mifepristone as the most evidence-based care for medical management of early pregnancy loss and to reaffirm its efforts to overturn restrictions on the prescribing of Mifepristone, especially considering data supporting its use in early pregnancy loss.

A substitute resolution was adopted by the 2019 Congress of Delegates.